open access

Vol 76, No 6 (2018)
Editorials
Published online: 2018-06-11
Submitted: 2018-05-07
Accepted: 2018-05-07
Get Citation

Familial hypercholesterolaemia: a look toward the East

Jean Ferrières
DOI: 10.5603/KP.2018.0116
·
Kardiol Pol 2018;76(6):935-936.

open access

Vol 76, No 6 (2018)
Editorials
Published online: 2018-06-11
Submitted: 2018-05-07
Accepted: 2018-05-07

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Familial hypercholesterolaemia: a look toward the East

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 76, No 6 (2018)

Pages

935-936

Published online

2018-06-11

DOI

10.5603/KP.2018.0116

Bibliographic record

Kardiol Pol 2018;76(6):935-936.

Authors

Jean Ferrières

References (14)
  1. Nordestgaard BG, Chapman MJ, Humphries SE, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J. 2013; 34(45): 3478–90a.
  2. Ferrières J, Lambert J, Lussier-Cacan S, et al. Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same LDL receptor gene mutation. Circulation. 1995; 92(3): 290–295.
  3. Ferrières J, Sing CF, Roy M, et al. Apolipoprotein E polymorphism and heterozygous familial hypercholesterolemia. Sex-specific effects. Arterioscler Thromb. 1994; 14(10): 1553–1560.
  4. Neil A, Cooper J, Betteridge J, et al. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study. Eur Heart J. 2008; 29(21): 2625–2633.
  5. Perak AM, Ning H, de Ferranti SD, et al. Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype. Circulation. 2016; 134(1): 9–19.
  6. Tada H, Kawashiri MA, Nohara A, et al. Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia. Eur Heart J. 2017; 38(20): 1573–1579.
  7. Grenkowitz T, Kassner U, Wühle-Demuth M, et al. Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia. Atherosclerosis. 2016; 253: 88–93.
  8. Talmud PJ, Shah S, Whittall R, et al. Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study. Lancet. 2013; 381(9874): 1293–1301.
  9. Ferrières J, Bruckert É, Béliard S, et al. [Familial hypercholesterolemia: A largely underestimated cardiovascular risk]. Ann Cardiol Angeiol (Paris). 2018; 67(1): 1–8.
  10. Séguro F, Bongard V, Bérard E, et al. Dutch Lipid Clinic Network low-density lipoprotein cholesterol criteria are associated with long-term mortality in the general population. Arch Cardiovasc Dis. 2015; 108(10): 511–518.
  11. Séguro F, Rabès JP, Taraszkiewicz D, et al. Genetic diagnosis of familial hypercholesterolemia is associated with a premature and high coronary heart disease risk. Clin Cardiol. 2018; 41(3): 385–391.
  12. Chlebus K, Cybulska B, Gruchała M, et al. Prevalence, diagnosis, and treatment of familial hypercholesterolaemia in outpatient practice in Poland. Kardiol Pol. 2018 [Epub ahead of print].
  13. Nichols M, Townsend N, Scarborough P, et al. Trends in age-specific coronary heart disease mortality in the European Union over three decades: 1980-2009. Eur Heart J. 2013; 34(39): 3017–3027.
  14. Pelczarska A, Jakubczyk M, Jakubiak-Lasocka J, et al. The cost-effectiveness of screening strategies for familial hypercholesterolaemia in Poland. Atherosclerosis. 2018; 270: 132–138.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl